OBJECTIVE: Questionnaires to screen for rheumatoid arthritis (RA) have been tested in groups that were primarily well educated and Caucasian. We sought to validate the RA questions of the Connective Tissue Disease Screening Questionnaire (CSQ) in ethnic minorities in an underserved community, and to test a Spanish-language version. METHODS: The Spanish-language version was developed by 2 native speakers. Consecutive English-speaking or Spanish-speaking patients in a community-based rheumatology practice completed the questionnaire. Diagnoses were confirmed by medical record review. Sensitivity and specificity of the questionnaire for a diagnosis of RA were computed for each language version, using 2 groups as controls: patients with noninflammatory conditions, and participants recruited from the community. RESULTS: The English-language version was tested in 53 patients with RA (79% ethnic minorities; mean education level 11.3 yrs), 85 rheumatology controls with noninflammatory conditions, and 82 community controls. Using 3 positive responses as indicating a positive screening test, the sensitivity of the questionnaire was 0.77, the specificity based on rheumatology controls was 0.45, and the specificity based on community controls was 0.94. The Spanish-language version was tested in 55 patients with RA (mean education level 7.8 yrs), 149 rheumatology controls, and 88 community controls. The sensitivity of the Spanish-language version was 0.87, with specificities of 0.60 and 0.97 using the rheumatology controls and community controls, respectively. CONCLUSION: The sensitivity of the English-language version of the RA questions of the CSQ was lower in this study than in other cohorts, reflecting differences in the performance of the questions in different ethnic or socioeconomic groups. The Spanish-language version demonstrated good sensitivity, and both had excellent specificity when tested in community controls.
OBJECTIVE: Questionnaires to screen for rheumatoid arthritis (RA) have been tested in groups that were primarily well educated and Caucasian. We sought to validate the RA questions of the Connective Tissue Disease Screening Questionnaire (CSQ) in ethnic minorities in an underserved community, and to test a Spanish-language version. METHODS: The Spanish-language version was developed by 2 native speakers. Consecutive English-speaking or Spanish-speaking patients in a community-based rheumatology practice completed the questionnaire. Diagnoses were confirmed by medical record review. Sensitivity and specificity of the questionnaire for a diagnosis of RA were computed for each language version, using 2 groups as controls: patients with noninflammatory conditions, and participants recruited from the community. RESULTS: The English-language version was tested in 53 patients with RA (79% ethnic minorities; mean education level 11.3 yrs), 85 rheumatology controls with noninflammatory conditions, and 82 community controls. Using 3 positive responses as indicating a positive screening test, the sensitivity of the questionnaire was 0.77, the specificity based on rheumatology controls was 0.45, and the specificity based on community controls was 0.94. The Spanish-language version was tested in 55 patients with RA (mean education level 7.8 yrs), 149 rheumatology controls, and 88 community controls. The sensitivity of the Spanish-language version was 0.87, with specificities of 0.60 and 0.97 using the rheumatology controls and community controls, respectively. CONCLUSION: The sensitivity of the English-language version of the RA questions of the CSQ was lower in this study than in other cohorts, reflecting differences in the performance of the questions in different ethnic or socioeconomic groups. The Spanish-language version demonstrated good sensitivity, and both had excellent specificity when tested in community controls.
Authors: E W Karlson; J Sanchez-Guerrero; E A Wright; R A Lew; L H Daltroy; J N Katz; M H Liang Journal: Ann Epidemiol Date: 1995-07 Impact factor: 3.797
Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra Journal: Arthritis Rheum Date: 1988-03
Authors: David J Hunter; Jingbo Niu; David T Felson; William F Harvey; K Douglas Gross; Paula McCree; Piran Aliabadi; Burton Sack; Yuqing Zhang Journal: Arthritis Rheum Date: 2007-04
Authors: Niall A M Klyn; Samantha Kleindienst Robler; Jamie Bogle; Razan Alfakir; Donald W Nielsen; James W Griffith; Deborah L Carlson; Larry Lundy; Sumitrajit Dhar; David A Zapala Journal: Ear Hear Date: 2019 Nov/Dec Impact factor: 3.570
Authors: Kevin D Deane; Christopher C Striebich; Barbara L Goldstein; Lezlie A Derber; Mark C Parish; Marie L Feser; Elaine M Hamburger; Stacey Brake; Cindy Belz; James Goddard; Jill M Norris; Elizabeth W Karlson; V Michael Holers Journal: Arthritis Rheum Date: 2009-12-15
Authors: Kimberly R Middleton; Michael M Ward; Steffany Haaz; Sinthujah Velummylum; Alice Fike; Ana T Acevedo; Gladys Tataw-Ayuketah; Laura Dietz; Barbara B Mittleman; Gwenyth R Wallen Journal: Health Qual Life Outcomes Date: 2013-04-02 Impact factor: 3.186
Authors: Laure Brulhart; Deshiré Alpízar-Rodríguez; Michael S Nissen; Pascal Zufferey; Ileana Ciubotariu; Gregory Fleury; Ilias Lazarou; Cem Gabay; Axel Finckh Journal: RMD Open Date: 2019-08-23